Table 1. Clinical signs and outcome of hamsters inoculated with NiV-M or NiV-B.
Inoculum | Dose (TCID50) | Survival (%) | Mean time to death (days)a |
NiV-M | 1×100 | 100 | N/A |
1×101 | 100 | N/A | |
1×102 | 40 | 8.7±1.7 | |
1×103 | 0 | 7.2±1.9* b | |
1×104 | 0 | 7±2 | |
1×105 | 0 | 5.8±0.7** c | |
NiV-B | 1×100 | 100 | N/A |
1×101 | 60 | 14±0 | |
1×102 | 100 | N/A | |
1×103 | 40 | 9±1.4* b | |
1×104 | 20 | 8.5±1.1 | |
1×105 | 20 | 7.75±0.8** c |
Excluding survivors.
Significant difference between NiV-M and NiV-B at dose 103 TCID50,
p<0.05: Log-rank test.
Significant difference between NiV-M and NiV-B at dose 105 TCID50,
p<0.01: Log-rank test.